Gyre Therapeutics (GYRE) Interest Coverage Ratio Growth (1y) (2011 - 2024)
Gyre Therapeutics (GYRE) Interest Coverage Ratio Growth (1y) (2011 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
147.23% |
| Dec 31, 2020 |
-164.51% |
| Dec 31, 2015 |
99.43% |
| Jun 30, 2015 |
84.68% |
| Dec 31, 2014 |
54.96% |
| Sep 30, 2014 |
67.60% |
| Jun 30, 2014 |
58.71% |
| Mar 31, 2014 |
59.97% |
| Dec 31, 2013 |
-47.32% |
| Sep 30, 2013 |
-149.75% |
| Jun 30, 2013 |
-237.87% |
| Mar 31, 2013 |
-777.00% |
| Dec 31, 2012 |
-193.84% |
| Sep 30, 2012 |
-69.23% |
| Jun 30, 2012 |
829.79% |
| Mar 31, 2012 |
-80.75% |
| Dec 31, 2011 |
-783.53% |
| Sep 30, 2011 |
-436.56% |
| Jun 30, 2011 |
-167.84% |
